| Lactose (India) Ltd | 142 Cr. | 113 | 247/84.3 | 32.4 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.63 Cr. | 1.90 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 5,021 Cr. | 461 | 479/192 | 113 | 22.8 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 34.0 Cr. | 45.9 | 92.2/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 35.8 Cr. | 24.4 | 29.1/17.0 | 37.3 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 64.3 Cr. | 85.4 | 134/78.9 | 17.0 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 52,080 Cr. | 1,845 | 2,286/1,275 | 39.1 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 344 Cr. | 15.1 | 22.5/10.8 | 20.9 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 730 Cr. | 1,546 | 1,785/635 | 31.2 | 299 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 105 Cr. | 21.0 | 32.0/15.0 | 32.1 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 837 Cr. | 284 | 449/219 | 8.00 | 123 | 0.88 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 11.1 Cr. | 4.44 | 9.28/2.11 | 6.28 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 375 Cr. | 387 | 477/112 | 60.4 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,708 Cr. | 1,080 | 1,584/1,045 | 45.9 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 55.2 Cr. | 0.27 | 1.24/0.26 | 3.63 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 47.1 Cr. | 19.6 | 26.3/6.40 | 48.6 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.93 Cr. | 9.83 | 17.2/9.01 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 177 Cr. | 494 | 896/443 | 9.56 | 563 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 71.0 Cr. | 71.0 | 71.5/26.1 | 182 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,237 Cr. | 1,455 | 2,452/1,345 | 42.6 | 173 | 0.74 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 20.2 Cr. | 44.2 | 88.7/37.6 | 43.9 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 18.4 Cr. | 7.37 | 7.37/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 18.5 Cr. | 123 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 38.8 Cr. | 71.0 | 71.0/9.41 | 431 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.2 Cr. | 40.0 | 80.0/0.00 | 42.5 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.03 Cr. | 20.1 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,512 Cr. | 607 | 1,028/470 | 29.8 | 72.4 | 0.20 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.8 Cr. | 20.3 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.9 Cr. | 23.5 | 43.7/17.4 | 51.8 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 97,707 Cr. | 2,370 | 3,055/2,115 | 54.0 | 355 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 238 Cr. | 413 | 524/241 | 24.9 | 119 | 1.09 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 44.8 Cr. | 31.2 | 62.6/31.2 | 40.3 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 67,362 Cr. | 1,149 | 1,417/994 | 19.9 | 557 | 0.35 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 122 Cr. | 196 | 303/170 | 177 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 877 Cr. | 87.4 | 123/74.0 | 19.0 | 32.5 | 1.71 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 39.8 Cr. | 30.5 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,980 Cr. | 1,831 | 1,868/919 | 66.9 | 160 | 0.08 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.23 Cr. | 0.64 | 1.45/0.55 | 84.6 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 249 Cr. | 32.6 | 68.0/30.0 | 13.3 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.71 Cr. | 14.9 | 25.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 135 Cr. | 5.75 | 6.57/2.82 | 315 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 62,371 Cr. | 29,400 | 37,000/25,260 | 43.0 | 1,992 | 1.62 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,661 Cr. | 845 | 972/550 | 28.8 | 220 | 0.59 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 278 Cr. | 98.2 | 98.2/31.3 | 66.9 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,733 Cr. | 1,560 | 1,628/535 | | 104 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,162 Cr. | 1,365 | 1,870/1,110 | 404 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 933 Cr. | 267 | 330/154 | 21.7 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 595 Cr. | 445 | 568/270 | 12.7 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,317 Cr. | 470 | 950/455 | 26.5 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,637 Cr. | 1,166 | 1,595/991 | 23.2 | 768 | 0.85 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,20,974 Cr. | 3,574 | 3,790/2,886 | 59.9 | 224 | 0.90 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,123 Cr. | 122 | 317/98.0 | | 43.7 | 0.41 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,542 Cr. | 16.4 | 24.0/14.1 | 27.1 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 28,369 Cr. | 742 | 1,360/725 | 80.7 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,488 Cr. | 197 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,05,945 Cr. | 1,693 | 1,910/1,547 | 35.4 | 301 | 0.95 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,735 Cr. | 616 | 886/441 | 112 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,633 Cr. | 282 | 319/175 | 37.5 | 75.9 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 367 Cr. | 1,229 | 1,680/956 | 21.2 | 650 | 0.12 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,984 Cr. | 358 | 502/265 | 54.3 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,512 Cr. | 219 | 232/111 | 183 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,937 Cr. | 4,751 | 6,718/4,146 | 29.6 | 340 | 2.46 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 4,095 Cr. | 2,471 | 2,776/1,772 | 36.7 | 335 | 0.81 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 10,047 Cr. | 6,056 | 6,739/4,904 | 33.4 | 323 | 2.06 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 170 Cr. | 48.2 | 87.5/42.0 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,457 Cr. | 5,123 | 5,993/3,701 | 34.7 | 922 | 0.68 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 122 Cr. | 99.2 | 348/81.0 | 8.62 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,660 Cr. | 434 | 582/281 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,025 Cr. | 792 | 1,998/604 | 47.2 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 22,634 Cr. | 17,633 | 18,100/10,060 | 172 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 314 Cr. | 14.2 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,701 Cr. | 820 | 1,505/660 | 8.66 | 425 | 0.73 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,635 Cr. | 48.2 | 91.7/41.7 | 28.5 | 21.1 | 0.41 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,460 Cr. | 187 | 359/162 | 24.2 | 54.4 | 0.43 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 104 Cr. | 66.0 | 130/62.8 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 338 Cr. | 94.9 | 177/90.2 | 45.1 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 91,174 Cr. | 1,998 | 2,403/1,774 | 24.6 | 377 | 0.60 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,054 Cr. | 526 | 980/499 | 12.2 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 53,024 Cr. | 982 | 986/474 | 77.6 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 933 Cr. | 899 | 1,235/596 | 21.4 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 153 Cr. | 70.8 | 129/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 797 Cr. | 165 | 327/154 | 22.8 | 107 | 1.82 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 672 Cr. | 385 | 500/265 | 24.0 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 18,777 Cr. | 1,178 | 1,310/802 | 37.8 | 414 | 0.42 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,531 Cr. | 1,696 | 1,952/1,303 | 38.7 | 221 | 0.91 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,445 Cr. | 216 | 328/193 | 33.0 | 38.0 | 1.16 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 32,822 Cr. | 1,294 | 1,758/1,168 | 36.7 | 274 | 0.31 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,726 Cr. | 92.9 | 127/57.5 | 25.8 | 57.5 | 0.85 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 748 Cr. | 102 | 124/67.2 | 33.9 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,536 Cr. | 275 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,962 Cr. | 240 | 465/236 | 46.8 | 102 | 0.57 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,359 Cr. | 1,597 | 2,786/1,243 | 36.1 | 369 | 0.43 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,284 Cr. | 328 | 504/285 | 53.7 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,721 Cr. | 565 | 628/412 | 28.8 | 153 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 52,107 Cr. | 1,846 | 2,286/1,275 | 39.1 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 45,113 Cr. | 2,663 | 3,516/1,921 | 47.7 | 115 | 1.58 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 31,399 Cr. | 1,906 | 2,131/1,200 | 27.1 | 610 | 0.94 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 7,306 Cr. | 449 | 553/359 | 27.2 | 140 | 1.10 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,588 Cr. | 1,585 | 1,910/1,097 | 55.7 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,00,220 Cr. | 1,201 | 1,406/1,020 | 17.4 | 432 | 0.67 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,666 Cr. | 298 | 322/177 | 39.3 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,634 Cr. | 1,506 | 1,673/1,310 | 22.4 | 408 | 0.85 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 15,164 Cr. | 1,995 | 2,641/1,551 | 26.8 | 347 | 0.30 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 327 Cr. | 111 | 203/95.6 | 161 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,627 Cr. | 154 | 191/105 | 15.2 | 99.7 | 0.32 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 64.4 Cr. | 39.6 | 72.0/38.0 | 23.1 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 50,925 Cr. | 381 | 406/291 | 141 | 180 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,751 Cr. | 1,735 | 2,215/1,430 | 38.2 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 130 Cr. | 81.5 | 141/76.3 | 18.1 | 48.6 | 1.46 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 403 Cr. | 170 | 179/67.8 | 40.0 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 23,973 Cr. | 9,589 | 10,691/6,220 | 113 | 308 | 0.33 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,079 Cr. | 719 | 843/544 | 38.1 | 113 | 0.63 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 187 Cr. | 88.8 | 137/85.0 | 7.08 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,673 Cr. | 5,660 | 5,961/4,492 | 29.7 | 1,002 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 18,761 Cr. | 954 | 1,153/725 | 31.6 | 264 | 1.16 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 498 Cr. | 873 | 1,540/763 | 79.2 | 688 | 0.57 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 32,546 Cr. | 2,605 | 3,147/2,022 | 33.4 | 345 | 1.08 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,497 Cr. | 312 | 509/258 | 25.5 | 127 | 1.65 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,618 Cr. | 502 | 575/312 | 25.8 | 136 | 0.20 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,834.08 Cr | 1,197.55 | | 54.46 | 195.42 | 0.33% | 16.24% | 14.95% | 6.10 |